Coronavirus Vaccine Stocks: Investors Cannot Overlook These Risks

Coronavirus Vaccine Stocks: Investors Cannot Overlook These Risks

If coronavirus vaccine development efforts are a race, then pharmaceutical companies will need to hurdle more than clinical trials to be successful.